Four-year-old Michelle Lowry is all about learning her letters and numbers, but her parents didnt know if they could count on seeing this day.<\/p>\n
What they thought was a ting bug bite on Michelles neck turned out to be a tumor.<\/p>\n
After a battery of tests, doctors at Childrens Hospital Los Angeles diagnosed Michelle with a soft tissue sarcoma.<\/p>\n
Because of the location, surgery and radiation were ruled out. Doctors used a new precise cancer panel called OncoKids to read Michelles DNA and RNA. The panel revealed Michelle would be a perfect candidate for a targeted new drug, larotrectinib.<\/p>\n
Doctors worked fast to get Michelle in a new clinical trial.<\/p>\n
Two months later Michelles tumor had shrunk by 60%. Two years later the tumor is undetectable.<\/p>\n
Based on other positive outcomes like Michelles, the FDA granted accelerated approval of larotrectinib.<\/p>\n
OncoKids is the first cancer panel designed specifically for childrens cancers and can detect genetic alterations for pediatric cancers, including leukemia, solid tumors, sarcomas and brain tumors.<\/p>\n
<\/p>\n
Go here to read the rest: Four-year-old Michelle Lowry is all about learning her letters and numbers, but her parents didnt know if they could count on seeing this day. Continue reading
\nHealthy Living: The Right Team, Timing and Treatment - 9&10 News<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"